Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Innovations in Genicular Outcomes Registry

NCT05495334 · tracked via the Priya Life Science USA tracker
Phase
Observational
Started
2021-09-23
Last updated
2026-07-23

Condition(s) studied

Knee Osteoarthritis

Investigational drug(s) / intervention(s)

Treatment for Knee OA

Treatment for Knee OA: Pain management treatment for knee OA.

Study summary

The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[NSAIDs\]).

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening 2. Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator 3. Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application Exclusion Criteria: 1. Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol 2. Planning to have a surgery other than on the target knee

Primary outcome measure(s)

  • Pain intensity and interference scores via NRS (Numeric Rating Scale) — 18 months
    NRS score from 0(being none)-10(being the worst)
  • Pain intensity and interference scores via BPI-sf (Brief Pain Inventory-short form) — 18 months
    Pain intensity and interference scores via BPI-sf 0 to 10, where: 0 = no pain and 10 = pain as bad as you can imagine
  • Opioid use via pre-and post-treatment analgesic medication use log — 18 months
    Opioid use via pre-and post-treatment analgesic medication use log
  • Functional status via KOOS-JR (Knee injury and Osteoarthritis Outcome Score for Joint Replacement) — 18 months
    Functional status via KOOS-JR. 0(none)-4(extreme)
  • Functional status via SANE (Single Assessment Numeric Evaluation) — 18 months
    Functional status via SANE. Percentage of normal (0% to 100% scale with 100% being normal)
  • Quality of Sleep via PROMIS-SD (PROMIS - Sleep Disturbance - Short Form 8b) — 18 months
    Quality of Sleep via PROMIS-SD. 1(Best)-5(Worst)
  • Adverse events related to pain therapies — 18 months
    Adverse events related to pain therapies
  • General HRQOL via PROMIS-10 (PROMIS GLOBAL-10) — 18 months
    General HRQOL via PROMIS-10. 1(Best)-5(Worst)
  • Patient Satisfaction — 18 months
    Patient satisfaction with pain management questionnaire (Patient Satisfaction Questionnaire). Two questions assessing satisfaction and benefit.
  • Physical therapy utilization and work productivity via PT/Work Productivity — 18 months
    Physical therapy (PT) utilization and work productivity via PT/Work Productivity (WP) questionnaire.
  • Emergency Department (ED) visits — 18 months
    Emergency Department (ED) visits
  • Reimbursement status — 18 months
    Reimbursement status
  • Post-operative pain scores NRS (Numeric Rating Scale) — 18 months
    Post-operative pain scores (NRS) 0(being none)-10(being the worst)
  • Post-operative opioid consumption (analgesic medication use log) — 18 months
    Post-operative opioid consumption (analgesic medication use log)
  • Length of facility stay — 18 months
    Length of facility stay

Trial sites (19)

FacilityCityRegionStatus
The MORE Foundation Phoenix Arizona Recruiting
Orthopedic Education and Research Institute of So Ca (Hoag) Irvine California Recruiting
Cedars-Sinai Medical Center Los Angeles California Recruiting
Florida Orthopaedic Associates DeLand Florida Recruiting
MidState Orthopedics and Sports Medicine Alexandria Louisiana Recruiting
Louisiana State University /Ochsner New Orleans Louisiana Recruiting
Sinai Hospital of Baltimore Baltimore Maryland Recruiting
Henry M Jackson Foundation for the Advancement of Military Medicine/Walter Reed National Military Medical Center Bethesda Maryland Terminated
Orthopaedic Surgical Associates North Chelmsford Massachusetts Recruiting
OrthoNebraska Clinics Omaha Nebraska Recruiting
Jersey City Medical Center Jersey City New Jersey Terminated
Northwell Health Garden City New York Recruiting
Genesee Orthopedics and Plastic Surgery (St. Elizabeth Med Center/ Apex Surgical Center) New Hartford New York Completed
Blue Nine Systems Asheville North Carolina Terminated
Oklahoma Surgical Hospital Tulsa Oklahoma Recruiting
Penn Highlands DuBois DuBois Pennsylvania Recruiting
University Orthopedics Center State College Pennsylvania Recruiting
Campbell Clinic Germantown Tennessee Recruiting
University of Utah Salt Lake City Utah Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05495334 on ClinicalTrials.gov ↗ ← All trials in the USA